Sign In  |   Enroll Now!  |   Quick Tour   
Live chat by SightMax

About Us


ARKRAY USA and signed a license agreement in May of 2010 that allowed ARKRAY to create ARK Care™. The following summaries and associated research outline the process MyCareTeam followed to create this ground-breaking system.

Studies & Results

MCT-Diabetes has been in active use by specific groups of people with Type 1 and Type 2 diabetes for several years. Appropriate glucose monitoring in groups of people with Type 1 or Type 2 diabetes provides effective management of blood sugar levels as measured by various parameters including HbA1C (Brigham & Women's Hospital and Harvard Medical School: McMahon et al. 2005; Georgetown University Medical Center: Smith et al. 2004)

Endocrinology Practice

Dr. Stephen Clement, an endocrinologist at Georgetown University Hospital, is using MCT-Diabetes with many of his patients.  Dr. Clement’s patients are followed regularly by a certified diabetes educator, Cherrel Christian, RN, CDE working with Dr. Clement.  The patients are instructed to transfer their blood glucose readings by directly connecting their glucose meters to a computer and uploading the data via MCT-Diabetes.  The patients use multiple vendors’ glucose meters, including those by Roche Diagnostics, TheraSense/Abbott, and LifeScan.  Ms. Christian regularly provides encouragement and information to the patients through the MCT-Diabetes web application and makes treatment changes as identified by Dr. Clement.

Boston Veteran’s Administration Hospital Study

(conducted by Brigham & Women’s Hospital and Harvard Medical School)
A randomized clinical control trial of MCT-Diabetes was carried out at the Boston Veterans Administration Hospital with patients that were randomly divided into one of two groups- usual care, or web-management with MCT-Diabetes.  The study compared HbA1C levels at baseline and after a period of 12 months.  Participants receiving web-based care management had a greater decline in HbA1C when compared to participants in the usual care group. 

Download Boston VA Study (PDF)

Georgetown Study

Patients with diabetes were enrolled in a pilot study of MCT-Diabetes at Georgetown University Medical Center.  Patients collected their blood glucose readings using Accu-Check® Complete™ blood glucose meters from Roche Diagnostics, Inc. Patients connected their blood glucose meters to their personal computers with Internet access to transmit their blood glucose readings weekly.  The glucose readings were transferred securely over the Internet to a central location where the patients and their care providers had secure access to the clinical data for review.  Graphical and statistical representations of their glucose readings and laboratory data highlighted areas of concern and identified patterns in their data.  Patients were automatically notified of lab values and blood glucose readings outside of identified target ranges. Providers evaluated the patient’s condition in between scheduled office visits.  Thus, areas of concern were identified before they became serious problems.

Download Georgetown Study (PDF)

Other Studies

Funding was recently received to implement MCT-Diabetes at Native American communities across the US and within the diabetes and pregnancy group at National Naval Medical Center in Bethesda, Maryland..  Since the MCT-Diabetes technology has already been proven in two previous studies, this study examines how culturally diverse populations respond to the MCT-Diabetes technology and how the technology can be used within the diabetes and pregnancy group of military personnel and their dependents.

Download Native American Study (PDF)